Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "CEO"

2066 News Found

Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier
Healthcare | December 08, 2025

Bengaluru healthtech firm Biomoneta secures USFDA nod for air purifier

Captured microbes are then neutralized on engineered microbicidal surfaces


Groundbreaking study identifies 250 genes driving ME & long COVID
R&D | December 08, 2025

Groundbreaking study identifies 250 genes driving ME & long COVID

76 of 180 long COVID-associated genes also linked to ME


Agilus Diagnostics launches comprehensive obesity & metabolic health test suite
Healthcare | December 08, 2025

Agilus Diagnostics launches comprehensive obesity & metabolic health test suite

The Vital Shape panels provide tiered assessments to detect obesity-related risks early


Praxis Precision hits milestone in fight against rare paediatric seizures
Clinical Trials | December 08, 2025

Praxis Precision hits milestone in fight against rare paediatric seizures

The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies


Paradigm Health to acquire Flatiron’s clinical research business
News | December 07, 2025

Paradigm Health to acquire Flatiron’s clinical research business

It's an acquisition that aims at forming one of the US's largest oncology trial networks


Biocon to merge Biocon Biologics in $5.5 billion deal
News | December 07, 2025

Biocon to merge Biocon Biologics in $5.5 billion deal

Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million


Lupin inks US licensing deal with Valorum for biosimilar Armlupeg
News | December 05, 2025

Lupin inks US licensing deal with Valorum for biosimilar Armlupeg

Valorum will advance the commercialization and distribution of Armlupeg in the United States


Terray Therapeutics hits milestone in collaboration with Bristol Myers Squibb
R&D | December 05, 2025

Terray Therapeutics hits milestone in collaboration with Bristol Myers Squibb

Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities


Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Startup | December 05, 2025

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions


Peapod Bio teams up with Enamine to supercharge drug discovery
R&D | December 05, 2025

Peapod Bio teams up with Enamine to supercharge drug discovery

Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target